PMC:7650537 / 5080-5260 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/PMC/sourceid/7650537","sourcedb":"PMC","sourceid":"7650537","source_url":"https://www.ncbi.nlm.nih.gov/pmc/7650537","text":"ted with the presence of virus-neutralizing antibodies [17]. To the best of our knowledge, clinically validated assays for the specific detection of IgG directed against the SARS-C","tracks":[{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T36","span":{"begin":149,"end":152},"obj":"Body_part"}],"attributes":[{"id":"A36","pred":"fma_id","subj":"T36","obj":"http://purl.org/sig/ont/fma/fma62872"},{"subj":"T36","pred":"source","obj":"LitCovid-PD-FMA-UBERON"}]},{"project":"LitCovid-PD-CLO","denotations":[{"id":"T36","span":{"begin":25,"end":30},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_10239"}],"attributes":[{"subj":"T36","pred":"source","obj":"LitCovid-PD-CLO"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"LitCovid-PD-FMA-UBERON","color":"#c593ec","default":true},{"id":"LitCovid-PD-CLO","color":"#93ecab"}]}]}}